Announcements Trials
Browse Landscape

Phase

Phase 1/2 24Phase 2 17Phase 1 11Phase 3 4Phase EARLY_PHASE1 1

Status

Completed 8Active not recruiting 6Terminated 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Microsatellite Instability 1Lymphoma, Large B-Cell, Diffuse 1Colonic Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × avelumab × Clear all
NCT03827044 2022-10-07

POLEM

Royal Marsden NHS Foundation Trust

Phase 3 Terminated
30 enrolled
Gastrointestinal

Colonic Neoplasms, Microsatellite Instability

NCT02952586 2021-09-22

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Pfizer

Phase 3 Terminated
697 enrolled 26 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02951156 2020-12-17

Javelin DLBCL

Pfizer

Phase 3 Terminated
29 enrolled 24 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02718417 2020-07-14

JAVELIN OVARIAN 100

Pfizer

Phase 3 Terminated
998 enrolled 39 charts
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡